GlassScriptPhysician profile
Jane Mireille Therrien
NPI 1306858030
$6,137.38
in general payments reported to CMS, 2019-2025
20 companies · $833 in 2025
The $833 reported for 2025 was more than what 88% of Optometrist providers received nationally (typical 2025 total: $204).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $405 · 2020: $290 · 2021: $1,200 · 2022: $982 · 2023: $976 · 2024: $1,452 · 2025: $833.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,260.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,260.44 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $2,140.76 | 2019-2025 | Dailies Total1, Dailies, Precision7 |
| Johnson & Johnson Vision Care, INC. | $729.02 | 2020-2025 | Acuvue |
| Sun Pharmaceutical Industries INC. | $493.08 | 2022-2024 | Cequa |
| Coopervision INC. | $489.40 | 2019-2025 | Misight Contact Lens |
| Bausch & Lomb Americas INC. | $458.43 | 2023-2025 | Miebo, Xiidra, Lotemax Sm |
| Tarsus Pharmaceuticals, INC. | $257.90 | 2024 | |
| Abbvie INC. | $213.53 | 2022 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $207.23 | 2019-2021 | |
| Glaukos Corporation | $174.03 | 2024 | Idose |
| Biotissue Holdings INC. | $165.93 | 2024 | |
| Amgen INC. | $121.87 | 2024 | |
| Astellas Pharma US INC | $121.83 | 2025 | Izervay |
| Horizon Therapeutics Plc | $119.36 | 2021 | |
| Rxsight INC | $115.38 | 2024 | Light Adjustable Lens (Lal), Rxsight Contact Lens, Rxsight Injector Cartridge |
| Regeneron Pharmaceuticals, INC. | $111.10 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Oyster Point Pharma, INC. | $108.71 | 2023 | Tyrvaya |
| Abb Con-Cise Optical Group LLC | $55.56 | 2025 | Contact Lens |
| Thea Pharma INC. | $19.82 | 2023 | |
| Carl Zeiss Meditec, INC. | $17.24 | 2020 | |
| Carl Zeiss Meditec Ag | $17.20 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jane Therrien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.